Decisionq Corporation

US Government As Represented by the Secretary of the Army

USA As Represented by Secretary of the Navy

John S Eberhardt, Iii

Jonathan A Forsberg

Thomas A Davis

Eric Elster

Trevor S Brown

Doug K Tadaki

Todd A Radano

Alexander Stojadinovic

Jason Hawksworth

Roslyn Bernstein Mannon

Benjamin E Peterson

Philip M Kalina

According to one aspect of the invention, health insurance claim data for a first group of individuals is obtained to generate a training corpus, including a training set of claim data and a holdout set of claim data. The first group of individuals represents enrollees of one or more first health insurance plans and the health insurance claim data represents historic insurance claim information for each individual in the first group. A Bayesian belief network (BBN) model is created by training a BBN network based on the training set of claim data using predetermined machine learning algorithms. The BBN model is validated using the holdout set of claim data. The BBN model, when having been successfully validated, is configured to identify at least one of individuals with risk for a disorder and individuals with risk who are most likely to benefit from intervention and treatment for the disorder.

Application of bayesian networks to patient screening and treatment

An embodiment of the invention provides a method for determining a patient-specific probability of disease. The method collects clinical parameters from a plurality of patients to create a training database. A fully unsupervised Bayesian Belief Network model is created using data from the training database; and, the fully unsupervised Bayesian Belief Network is validated. Clinical parameters are collected from an individual patient; and, such clinical parameters are input into the fully unsupervised Bayesian Belief Network model via a graphical user interface. The patient-specific probability of the healing rate of an acute traumatic wound is output from the fully unsupervised Bayesian Belief Network model and sent to the graphical user interface for use by a clinician in pre-operative planning. The fully unsupervised Bayesian Belief Network model is updated using the clinical parameters from the individual patient and the patient-specific probability of the healing rate of an acute traumatic wound.

Clinical decision model

According to one embodiment, in response to a set of data for anomaly detection, a Bayesian belief network (BBN) model is applied to the data set, including for each of a plurality of features of the BBN model, performing an estimate using known observed values associated with remaining features to generate a posterior probability for the corresponding feature. A scoring operation is performed using a predetermined scoring algorithm on posterior probabilities of all of the features to generate a similarity score, wherein the similarity score represents a degree to which a given event represented by the data set is novel relative to historical events represented by the BBN model.

Application of machine learned Bayesian networks to detection of anomalies in complex systems

An embodiment of the invention provides a method for determining a patient-specific probability of transplant glomerulopathy. The method collects clinical parameters from a plurality of patients to create a training database. A fully unsupervised Bayesian Belief Network model is created using data from the training database; and, the fully unsupervised Bayesian Belief Network is validated. Clinical parameters are collected from an individual patient; and, such clinical parameters are input into the fully unsupervised Bayesian Belief Network model via a graphical user interface. The patient-specific probability of transplant glomerulopathy is output from the fully unsupervised Bayesian Belief Network model and sent to the graphical user interface for use by a clinician in pre-operative planning. The fully unsupervised Bayesian Belief Network model is updated using the clinical parameters from the individual patient and the patient-specific probability of transplant glomerulopathy.

Bayesian clinical decision model for determining probability of transplant glomerulopathy

Growing community of inventors

Washington, DC, United States of America

John S Eberhardt, Iii